Stress Reduction in Ovarian Cancer



Status:Completed
Conditions:Ovarian Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:February 2013
End Date:December 6, 2016

Use our guide to learn which trials are right for you!

Stress Reduction During Primary Adjuvant Chemotherapy for Ovarian Cancer

The purpose of this study is to investigate the effects of a stress reduction program on the
quality of life of ovarian cancer patients during primary adjuvant chemotherapy.


Inclusion Criteria:

- Subjects must have an initial diagnosis of ovarian, fallopian tube or primary
peritoneal cancer who completed primary ovarian cancer surgery or 3 cycles of
neoadjuvant chemotherapy with interval cytoreductive surgery (ICS).

- Final pathology diagnosis of stage I-IV ovarian, fallopian tube or primary peritoneal
cancer with plan to receive primary adjuvant chemotherapy or completion of
chemotherapy after ICS.

- Receive chemotherapy at the University of Wisconsin-Madison.

- Subjects must be at least 18 years of age.

- English-speaking

- Subjects must be able to use audio media, and read and understand the study manual.

- ECOG performance status 0-2.

- Subjects must have a phone.

Exclusion Criteria:

- Subjects participating in a meditation practice more than 1 hour per week prior to
surgery and/or chemotherapy administration.

- Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer.

- Subjects with diagnosis of Chronic Fatigue Syndrome (CFS).

- Subjects unable to use audio media due to auditory dysfunction.

- Subjects unable to read written English.

- Subjects who are prisoners or incarcerated.
We found this trial at
1
site
750 Highland Avenue
Madison, Wisconsin 53792
Principal Investigator: Stephen Rose, MD
Phone: 800-622-8922
?
mi
from
Madison, WI
Click here to add this to my saved trials